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httpIntroduction: Bartonella spp. is a highly unusual cause of mycotic aneurysms. We describe the ﬁrst case of an
infected aortic aneurysm secondary to Bartonella henselae endocarditis in an immunocompromised patient.
Report: A 72-year-old woman presented with severe left lower quadrant pain. Computed tomography
angiography showed an infrarenal mycotic aneurysm, and transoesophageal echocardiogram revealed aortic
valve vegetation. Serology conﬁrmed the presence of B. henselae endocarditis. Given the patient’s comorbidities,
the aneurysm was successfully treated by endovascular repair and antibiotic therapy.
Discussion: Endovascular stent-grafting is an alternative treatment option for mycotic aneurysms in high-risk
patients who are unsuitable for open repair.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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A 72-year-old woman presented to the emergency depart-
ment with a 1-week history of left lower abdominal pain.
The patient’s medical history was signiﬁcant for peptic ulcer
disease, colonic polyps, and recent epigastric hernia repair.
Cardiovascular risk factors included heavy smoking, hyper-
tension, diabetes mellitus type II, dyslipidemia, ischemic
heart disease, and signiﬁcant peripheral vascular disease.
The patient was apyrexial. Physical examination revealed
left iliac fossa pain and tenderness suggestive of acute
diverticulitis. Empiric antibiotic therapy with intravenous
amoxicillineclavulanate and metronidazole was
commenced. Laboratory tests showed an elevated C-reac-
tive protein (30 mg/L [<5 mg/L]) and raised white blood
cell count (14.9 109/L [4.5e11.0  109/L]) with signiﬁcant
monocytosis (4.44 [0.03e0.07]). A peripheral blood smear
was consistent with a diagnosis of chronic myelomonocytic
leukemia. Blood cultures and Salmonella fecal cultures were
negative. A computer tomographic angiogram (CTA)
demonstrated a 4.3-cm infrarenal saccular aortic aneurysm
and severe stenosis of the right common iliac artery (Figs. 1
and 2A). There was radiological evidence of soft tissue
inﬂammation (“stranding”), which was indicative of the
mycotic nature of this aneurysm. A transesophageal echo-
cardiogram revealed aortic valve vegetation with an ejec-
tion fraction of 20%. Serology detected signiﬁcant IgG levels
against Bartonella henselae (1:512) consistent with a diag-
nosis of culture-negative endocarditis.of original article: http://dx.doi.org/10.1016/j.ejvs.2014.05.004
rresponding author. P.A. Naughton, Department of Vascular Surgery,
ont Hospital, Beaumont Road, Dublin 9, Ireland.
il address: pnaughton@rcsi.ie (P.A. Naughton).
-3167/$ e see front matter  2014 European Society for Vascular
y. Published by Elsevier Ltd. All rights reserved.
://dx.doi.org/10.1016/j.ejvsextra.2014.05.002Considering this patient’s comorbidities, the patient was
deemed unﬁt for open aortic repair and underwent endo-
vascular aneurysm repair (EVAR). In view of the chronic
critical stenosis of the right common iliac artery, it was
elected to deploy an aorto-uniliac stent-graft introduced via
the left side rather than a bifurcated device (Endurant;
Medtronic, Minneapolis, MN, USA) A rifampicin-soaked 8-
mm graft was used to perform a femoro-femoral bypass.
The patient made a good recovery following 12 weeks of
antibiotic therapy with intravenous ceftriaxone and genta-
micin, and appeared well at 7 months postintervention,
with radiological evidence of good blood ﬂow through the
stent graft (Fig. 2B).DISCUSSION
While mycotic aneurysms represent an overall rare entity,
they are associated with a particularly poor prognosis and
signiﬁcant mortality.1,2 Predisposing factors for the devel-
opment of mycotic aneurysms include extensive athero-
sclerotic disease and impaired immunity. Patients are
frequently older, immunocompromised individuals with
signiﬁcant comorbidities.2 In addition, the high risk of
rupture contributes to the challenging surgical repair.1,2 The
presence of a saccular or lobulated aneurysm with sur-
rounding soft tissue inﬂammation on CTA is suggestive of a
mycotic aneurysm.3 Following diagnosis, urgent surgical
repair is necessary to prevent aneurysm-related deaths.2
Overall, Salmonella spp. and Staphylococcus aureus are
the most common causative organisms;2 however, immu-
nocompromised individuals are more susceptible to in-
fections by unusual organisms, as in this case. Bartonella
henselae is a Gram-negative bacillus that is transmitted to
humans via an arthropod vector or scratches from inter-
mediate hosts, such as cats or dogs.4 While Bartonella is a
well-described agent of culture-negative endocarditis, only
Figure 1. (A) Axial, (B) sagittal, and (C) coronal views of the preoperative computer tomographic angiogram showing the 4.3-cm infrarenal
aortic aneurysm.
Figure 2. (A) Preoperative three-dimensional (3D) computed to-
mography (CT) scan displaying the stenosis of the right common
iliac artery; (B) post-operative 3D CT scan demonstrating patency
of the aorto-uni-iliac stent graft and femoro-femoral bypass.
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tana has been reported.5 This, to the authors’ knowledge, is
the ﬁrst reported case of a mycotic aneurysm secondary to
B. henselae endocarditis. Diagnosis of Bartonella endo-
carditis requires a high index of suspicion in an immuno-
compromised patient presenting with culture-negative
endocarditis, as in this case. Fortunately, these infections
respond well to antibiotic therapy.4
Owing to high reinfection rates, aggressive surgical
debridement of the infective tissue and open vascular
reconstruction remain the gold standard treatment for
mycotic aneurysms. However, despite the increased infec-
tion risk, EVAR combined with prolonged antibiotic therapy
has recently emerged as a viable alternative, particularly inhigh-risk patients. The presence of pyrexia and aneurysm
rupture have been associated with poor outcome following
EVAR of mycotic aneurysms. EVAR signiﬁcantly reduces
perioperative mortality, especially in patients at high risk for
open surgery.1 Owing to the severe cardiovascular comor-
bidities, endovascular stent-grafting combined with
aggressive antibiotic therapy represented a feasible treat-
ment option in this care as lower perioperative morbidity
and mortality outweighed the risks of prolonged infection.
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